source
- Pharma is betting big on PD-1/VEGF bispecifics. But are companies chasing the wrong target?While many drugmakers are focused on lung cancer, evidence shows the liver may be a better bet.BioPharma Dive · 1mo ago↗ source
- Otsuka touts new IgAN evidence as it seeks full approval for VoyxactOtsuka Pharmaceutical reported new evidence on Thursday that it thinks will help support a full approval for its monoclonal antibody Voyxact in a chronic autoimmune disease that affects the kidneys…Endpoints · 1mo ago↗ source
- Acting FDA chief isn't interested in permanent roleActing FDA Commissioner Kyle Diamantas isn't interested in keeping the job and the search for a permanent replacement is progressing, according to a source familiar with the process. An announcemen…Endpoints